Accessibility Menu
Fresenius Medical Care logo

Fresenius Medical Care(NYSE) FMS

Market Cap$12.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)+225%
5 Year-31%
1 Year+3%
1 Month-1%
$23.92
-1.79%
-0.43Today
After hours$23.88-$0.04 (-0.17%)
Fresenius Medical Care last closing stock price
MetricPriceDate
Last closeUSD 23.872026-08-11
Fresenius Medical Care stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.58%USD 24.012026-08-04
1 month-0.62%USD 24.022026-07-10
3 month+16.05%USD 20.572026-05-13
Year to date+4.21%USD 22.902025-12-31
1 year+2.96%USD 23.182025-08-11
3 year+0.76%USD 23.692023-08-11
5 year-30.97%USD 34.582021-08-12
Since inception+224.77%USD 7.501996-09-17

Fresenius Medical Care Financials at a Glance

Market Cap

$12.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€19.43B

Net Income (TTM)

€937.78M

EPS (TTM)

$1.94

P/E Ratio

12.32

Dividend

$0.86

Beta (Volatility)

0.46 (Low)

Price

$23.92

Volume

0.15

Open

$24.36

Previous Close

$23.87

Daily Range

$23.85 - $24.54

52-Week Range

$20.02 - $27.64

Estimated Earnings Date

Nov 3, 2026

FMS News

Senior patient looking through window at hospital

Why Shares of Fresenius Medical Care Were Dropping on Wednesday

James HalleyOct 11, 2023
doctors white coat healthcare (1)

Why Shares of Fresenius Medical Jumped This Week

James HalleyJul 14, 2023
Patient checking in for a doctor's appointment

3 Stocks With Dividends of 3% or More to Buy on the Dip

James HalleyNov 14, 2022
GettyImages-1012405368

Where Will Cara Therapeutics Be in 5 Years?

Mark PrvulovicJan 31, 2020
people working in a lab

Better Buy: Cara Therapeutics vs. Fresenius

David Jagielski, CPAJan 4, 2020
bank building

2 Bargain Stocks You Can Buy Today

David Jagielski, CPADec 19, 2019
dialysis patient

Why Fresenius Medical Care’s Stock Fell 24% in October

Demitri KalogeropoulosNov 12, 2018
SHOP logo

Why Shopify, Fresenius Medical Care, and Tilray Slumped Today

Dan CaplingerOct 17, 2018
Page 1

FMS: Motley Fool Moneyball Superscore

64

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fresenius Medical Care

Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. The company delivers essential dialysis therapy through an extensive network of outpatient clinics and provides necessary equipment for home-based care.

Products and Services
  • Dialysis therapy and associated laboratory services
  • Home-based dialysis equipment and patient training
  • Development and distribution of renal pharmaceuticals and medical devices
Growth Outlook
  • Managed 4,171 outpatient dialysis clinics globally as of February 2022
  • Strong demand for dialysis services due to rising chronic kidney disease cases
  • Focus on expanding home dialysis options to enhance patient care
Financial Highlights
  • Q1 2026 revenue of €4.61 billion, reflecting steady demand
  • Trailing twelve months (TTM) net income margin of 4.88%
  • Dividend yield of 3.52%, indicating shareholder return commitment
AI Generated • Jul 21, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

107,226

CEO

Helen Giza, MBA

Website

www.freseniusmedicalcare.com/de

Headquarters

Bad Homburg, HE 61352, DE

FMS Financials

Key Financial Metrics (TTM)

Gross Margin

26.36%

Operating Margin

10.69%

Net Income Margin

4.83%

Return on Equity

7.21%

Return on Capital

7.28%

Return on Assets

3.00%

Earnings Yield

8.12%

Dividend Yield

3.62%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

532.22M

Volume

0.15

Avg. Volume

761.01K

Financials (TTM)

Gross Profit

€5.12B

Operating Income

€1.89B

EBITDA

€3.42B

Operating Cash Flow

€2.80B

Capital Expenditure

-€1.03B

Free Cash Flow

€1.77B

Cash & ST Invst.

€1.45B

Total Debt

€10.96B

Fresenius Medical Care Performance Analysis

Fresenius Medical Care annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 20,383,982,131-2.1%
20232023-12-31EUR 21,032,149,4313.2%
20242024-12-31EUR 20,917,464,341-0.5%
20252025-12-31EUR 22,161,735,1155.9%
Fresenius Medical Care sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.9%
Q42025-12-313.8%
Q12026-03-31-9.0%
Q22026-06-305.4%
Fresenius Medical Care annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 1.21-38.3%
20232023-12-31EUR 0.92-23.8%
20242024-12-31EUR 0.997.9%
20252025-12-31EUR 1.9091.2%
Fresenius Medical Care sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3022.1%
Q42025-12-3121.3%
Q12026-03-31-62.3%
Q22026-06-3088.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€4.86B

+1.4%

Gross Profit

€1.31B

+7.9%

Gross Margin

26.95%

N/A

Market Cap

$12.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$117.45K

N/A

Employees

108,165

N/A

Net Income

€218.38M

-3.1%

EBITDA

€823.01M

+0.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€1.45B

-33.8%

Total Debt

€10.96B

-0.6%

Accounts Receivable

€3.47B

+7.2%

Inventory

€2.33B

+16.8%

Long Term Debt

€8.64B

-8.3%

Short Term Debt

€2.33B

+45.0%

Return on Assets

3.00%

N/A

Return on Invested Capital

8.61%

N/A

Free Cash Flow

€619.90M

-0.1%

Operating Cash Flow

€860.30M

+11.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ICLRICON Public Limited Company
$165.58-0.28%
SNNSmith & Nephew plc
$30.01-0.23%
EHCEncompass Health Corporation
$125.35-0.37%
DVADaVita Inc.
$178.34-2.91%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.44+0.03%
SMCISuper Micro Computer
$31.60+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.06-0.01%
INTCIntel
$97.71+0.00%

Questions About FMS

What is the current price of Fresenius Medical Care?

Fresenius Medical Care is trading at $23.87 per share.

What is the 52-week range for Fresenius Medical Care?

Over the past 52 weeks, Fresenius Medical Care has traded between $20.02 and $27.64.

How much debt does Fresenius Medical Care have?

As of the most recent reporting period, Fresenius Medical Care reported total debt of €12.53B.

How much cash does Fresenius Medical Care have on hand?

Fresenius Medical Care reported €1.21B in cash and cash equivalents in its most recent financial results.

What is Fresenius Medical Care’s dividend yield?

Fresenius Medical Care currently has a dividend yield of 3.62%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services